ストックスクリーナーアプリを入手
0.00
100.00%
-4.36
前日終値:
$4.36
開ける：
$0
24時間の取引高:
0
Relative Volume:
0.00
時価総額：
$96.26M
収益：
-
当期純損益:
$-94.11M
株価収益率:
0.00
EPS:
-6.01
ネットキャッシュフロー:
$-86.06M
1週間 パフォーマンス:
-100.00%
1か月 パフォーマンス:
-100.00%
6か月 パフォーマンス:
-100.00%
1年 パフォーマンス:
-100.00%
1日の値動き範囲:
$0.00
$0.00
1週間の範囲:
$0.00
$0.00
52週間の値動き範囲:
$0.00
$5.75
Adverum Biotechnologies Inc Stock (ADVM) Company Profile
名前
Adverum Biotechnologies Inc
セクター
電話
(650) 649-1004
住所
100 CARDINAL WAY, REDWOOD CITY, CA
ADVM を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ADVM
Adverum Biotechnologies Inc
|
0.00 | 96.26M | 0 | -94.11M | -86.06M | -6.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
456.07 | 115.62B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
742.62 | 79.10B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
848.93 | 52.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
396.27 | 51.72B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
200.62 | 42.00B | 447.02M | -1.18B | -906.14M | -6.1812 |
Adverum Biotechnologies Inc Stock (ADVM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-17 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2024-06-25 | 開始されました | Oppenheimer | Outperform |
| 2024-04-30 | 開始されました | H.C. Wainwright | Buy |
| 2022-07-07 | アップグレード | Truist | Hold → Buy |
| 2021-07-23 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2021-05-03 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2021-04-29 | ダウングレード | Chardan Capital Markets | Buy → Neutral |
| 2021-04-29 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-04-29 | ダウングレード | Truist | Buy → Hold |
| 2020-12-16 | 開始されました | UBS | Neutral |
| 2020-11-12 | アップグレード | Raymond James | Underperform → Mkt Perform |
| 2020-06-26 | ダウングレード | Raymond James | Mkt Perform → Underperform |
| 2020-05-13 | 開始されました | RBC Capital Mkts | Outperform |
| 2020-05-05 | アップグレード | SunTrust | Hold → Buy |
| 2020-04-28 | 開始されました | Goldman | Buy |
| 2020-03-16 | 開始されました | SVB Leerink | Outperform |
| 2020-02-10 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2020-02-10 | アップグレード | Chardan Capital Markets | Neutral → Buy |
| 2019-10-15 | 繰り返されました | Chardan Capital Markets | Neutral |
| 2019-09-13 | 繰り返されました | Chardan Capital Markets | Neutral |
| 2019-06-14 | 再開されました | Raymond James | Mkt Perform |
| 2018-11-02 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2018-11-02 | ダウングレード | SunTrust | Buy → Hold |
| 2018-09-21 | 開始されました | Cantor Fitzgerald | Overweight |
| 2018-08-30 | 開始されました | SunTrust | Buy |
| 2018-02-15 | 再開されました | Piper Jaffray | Overweight |
| 2017-10-12 | 開始されました | Raymond James | Outperform |
すべてを表示
Adverum Biotechnologies Inc (ADVM) 最新ニュース
Adverum Biotechnologies (NASDAQ:ADVM) Lowered to "Strong Sell" Rating by Wall Street Zen - MarketBeat
Adverum Biotechnologies (NASDAQ:ADVM) Lowered to “Strong Sell” Rating by Wall Street Zen - Defense World
Market Catalysts: Why hedge funds are buying Adverum Biotechnologies Inc stockJuly 2025 Spike Watch & Consistent Return Investment Signals - moha.gov.vn
Hedge Fund and Insider Trading News: Cathie Wood, Michael Burry, Renaissance Technologies, Mason Capital, Millennium Management, Adverum Biotechnologies Inc (ADVM), MGM Resorts International (MGM), and More - Insider Monkey
Adverum Biotechnologies, Inc.(NasdaqCM: ADVM) dropped from S&P TMI Index - marketscreener.com
Lilly and Adverum announce expiration and completion of Adverum tender offer and acquisition - The Malaysian Reserve
Eli Lilly (LLY) Completes Acquisition of Adverum Biotechnologies - GuruFocus
Eli Lilly Moves Forward With Acquisition Of Adverum Biotechnologies - Nasdaq
Lilly completes tender offer for Adverum Biotechnologies - Investing.com
Monday’s Insider Moves: Adverum Execs Lead Buys, Diamondback Sale Tops - Investing.com Australia
Adverum Biotechnologies Stock (ADVM) Opinions on Lilly Acquisition - Quiver Quantitative
Lilly completes tender offer for Adverum Biotechnologies By Investing.com - Investing.com UK
Lilly completes Adverum acquisition for $3.56 per share plus CVRs - StreetInsider
Adverum Biotechnologies (NASDAQ:ADVM) CEO Buys $47,000.40 in Stock - MarketBeat
Insider Buying: Laurent Fischer Acquires Shares of Adverum Biote - GuruFocus
Soparkar Peter, Adverum Biotechnologies COO, buys $211k in shares By Investing.com - Investing.com Canada
Adverum biotechnologies CEO Fischer buys shares worth $553916 By Investing.com - Investing.com Canada
Adverum Biotechnologies (NASDAQ:ADVM) Major Shareholder Sells $2,197,906.40 in Stock - Defense World
Insider Selling: Adverum Biotechnologies (NASDAQ:ADVM) Major Shareholder Sells $2,197,906.40 in Stock - MarketBeat
What analysts say about Adverum Biotechnologies Inc stockEarnings Per Share Trends & Try Our Free Strategy Builder Now - earlytimes.in
Owner Leonard Sells 524,560 ($2.2M) Of Adverum Biotechnologies Inc [ADVM] - TradingView
Adverum Reminds Stockholders to Tender Their Shares Into the Offer by Lilly - 富途牛牛
LUNA Surges 20% in a Day Amid Ongoing Terra Network Upgrade - Bitget
Why retail traders accumulate Adverum Biotechnologies Inc. (AVU0) stockWeekly Profit Report & Advanced Swing Trade Entry Alerts - Newser
Insider Selling: Adverum Biotechnologies (NASDAQ:ADVM) Major Shareholder Sells 222,925 Shares of Stock - MarketBeat
Adverum Biotechnologies (NASDAQ:ADVM) Major Shareholder Braden Michael Leonard Sells 51,961 Shares - MarketBeat
Adverum Biotechnologies Releases Promising Phase 2 Trial Data - TipRanks
Adverum Biotechnologies, Inc. Announces Two-Year Data from LUNA Phase 2 Trial - TradingView — Track All Markets
How Adverum Biotechnologies Inc. (AVU0) stock reacts to stronger dollarJuly 2025 Highlights & Growth Oriented Trade Recommendations - Newser
Why Adverum Biotechnologies Inc. (AVU0) stock trades below fair valueMarket Performance Summary & Reliable Volume Spike Trade Alerts - Newser
Is Adverum Biotechnologies Inc. (AVU0) stock resilient in recession scenariosQuarterly Earnings Report & Entry and Exit Point Strategies - Newser
Leonard of Adverum Bio sells $2.4m in shares By Investing.com - Investing.com Canada
Owner Leonard Sells 574,886 ($2.4M) Of Adverum Biotechnologies Inc [ADVM] - TradingView
Is Adverum Biotechnologies Inc. (AVU0) stock undervalued by metricsJuly 2025 Catalysts & Safe Capital Investment Plans - Newser
Published on: 2025-12-02 05:06:35 - Newser
What technical patterns form on Adverum Biotechnologies Inc. (AVU0) stock charts - Newser
Will Adverum Biotechnologies Inc. (AVU0) stock return to pre crash levelsMarket Growth Review & Consistent Profit Trading Strategies - Newser
How Adverum Biotechnologies Inc. (AVU0) stock performs in volatility spikesQuarterly Market Review & Precise Trade Entry Recommendations - Newser
Eli Lilly’s tender offer for Adverum nears deadline amid liquidity concerns - Investing.com Canada
Adverum reminds stockholders to tender their shares into the offer by Lilly - marketscreener.com
Eli Lilly (LLY) Sets Tender Offer to Acquire Adverum Biotechnolo - GuruFocus
Eli Lilly’s tender offer for Adverum nears deadline amid liquidity concerns By Investing.com - Investing.com South Africa
Adverum Reminds Stockholders to Tender their Shares into the Offer by Lilly - The Manila Times
Bronstein, Gewirtz & Grossman, LLC Is Investigating Adverum Biote - The National Law Review
Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Adverum Biotechnologies Faces Lease Termination Notice - TipRanks
Adverum Biotechnologies IncARE-NC Region No. 21 LLC terminates certain lease agreement with Adverum BiotechnologiesSEC filing - MarketScreener
[8-K] Adverum Biotechnologies, Inc. Reports Material Event | ADVM SEC FilingForm 8-K - Stock Titan
Lilly strengthens gene therapy portfolio with MeiraGTx and Adverum deals - Drug Discovery News
Chart overlay techniques for tracking Adverum Biotechnologies Inc.2025 Price Targets & Low Risk Growth Stock Ideas - newser.com
Is Adverum Biotechnologies Inc. stock cheap compared to fundamentals2025 Retail Activity & Weekly High Momentum Picks - newser.com
Adverum Biotechnologies Inc (ADVM) 財務データ
収益
当期純利益
現金流量
EPS
Adverum Biotechnologies Inc (ADVM) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Rubinstein Linda M | CHIEF FINANCIAL OFFICER |
Dec 09 '25 |
Option Exercise |
4.20 |
48,750 |
204,750 |
61,150 |
| Fischer Laurent | CEO, PRESIDENT AND DIRECTOR |
Dec 08 '25 |
Buy |
4.31 |
117,614 |
506,916 |
201,513 |
| Fischer Laurent | CEO, PRESIDENT AND DIRECTOR |
Dec 05 '25 |
Buy |
4.24 |
11,085 |
47,000 |
83,899 |
| Soparkar Peter | CHIEF OPERATING OFFICER |
Dec 05 '25 |
Buy |
4.22 |
50,000 |
211,000 |
80,189 |
| Leonard Braden Michael | 10% Owner |
Dec 04 '25 |
Sale |
4.19 |
524,560 |
2,200,372 |
1,958,080 |
| Leonard Braden Michael | 10% Owner |
Dec 01 '25 |
Sale |
4.20 |
300,000 |
1,260,000 |
2,757,526 |
| Leonard Braden Michael | 10% Owner |
Dec 03 '25 |
Sale |
4.17 |
222,925 |
929,597 |
2,428,640 |
| Leonard Braden Michael | 10% Owner |
Dec 02 '25 |
Sale |
4.20 |
51,961 |
218,236 |
2,705,565 |
| Soparkar Peter | CHIEF OPERATING OFFICER |
May 15 '25 |
Sale |
2.00 |
2,960 |
5,920 |
39,154 |
| Seyedkazemi Setareh | CHIEF DEVELOPMENT OFFICER |
May 15 '25 |
Sale |
2.00 |
924 |
1,848 |
13,768 |
0.42%
0.32%
大文字化:
|
ボリューム (24 時間):